» Articles » PMID: 34702986

A Review of Public Health, Social and Ethical Implications of Voluntary Medical Male Circumcision Programs for HIV Prevention in Sub-Saharan Africa

Overview
Journal Int J Impot Res
Date 2021 Oct 27
PMID 34702986
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Ideally, the benefits of public health interventions should outweigh any associated harms, burdens, and adverse unintended consequences. The intended benefit of voluntary medical male circumcision (VMMC) programs in eastern and southern Africa (ESA) is the reduction of HIV infections. We review the literature for evidence of reductions in HIV incidence, evaluate the extent to which decreases in HIV incidence can be reasonably attributed to VMMC programs, and summarize social harms and ethical concerns associated with these programs. Review findings suggest that HIV incidence had been declining across ESA since before the large-scale rollout of VMMC as a public health intervention, and that this decline may be due to the combined effects of HIV prevention and treatment interventions, such as expanded antiretroviral therapy. The independent effect of VMMC programs in reducing HIV infections at the population level remains unknown. On the other hand, VMMC-associated evidence is increasing for the existence of negative social impacts such as stigmatization and/or discrimination, and ethically problematic practices, including lack of informed consent. We conclude that the relationship between the benefits and burdens of VMMC programs may be more unfavorable than what has been commonly suggested by proponents of global VMMC campaigns.

Citing Articles

Ethics of Mathematical Modeling in Public Health: The Case of Medical Male Circumcision for HIV Prevention in Africa.

Rennie S, Levintow S, Gilbertson A, Luseno W Public Health Ethics. 2024; 17(3):125-138.

PMID: 39678390 PMC: 11638778. DOI: 10.1093/phe/phae009.


Rethinking the Definition of Medicalized Female Genital Mutilation/Cutting.

Van Eekert N, Barrett H, Kimani S, Hidayana I, Leye E Arch Sex Behav. 2024; 53(2):441-453.

PMID: 38286965 DOI: 10.1007/s10508-023-02772-7.

References
1.
H Gray R, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F . Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007; 369(9562):657-66. DOI: 10.1016/S0140-6736(07)60313-4. View

2.
Bailey R, Moses S, Parker C, Agot K, Maclean I, Krieger J . Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562):643-56. DOI: 10.1016/S0140-6736(07)60312-2. View

3.
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A . Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005; 2(11):e298. PMC: 1262556. DOI: 10.1371/journal.pmed.0020298. View

3.
Carrasco M, Wilkinson J, Kasdan B, Fleming P . Systematic review of barriers and facilitators to voluntary medical male circumcision in priority countries and programmatic implications for service uptake. Glob Public Health. 2018; 14(1):91-111. DOI: 10.1080/17441692.2018.1465108. View

4.
Carrasco M, Grund J, Davis S, Ridzon R, Mattingly M, Wilkinson J . Systematic review of the effect of economic compensation and incentives on uptake of voluntary medical male circumcision among men in sub-Saharan Africa. AIDS Care. 2018; 30(9):1071-1082. PMC: 6800131. DOI: 10.1080/09540121.2018.1453921. View